MedTrace Logo

Preoperative Misoprostol in Reducing Blood Loss in Total Abdominal Hysterectomy (TAH)

NCT01199159 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 77

Last updated 2010-09-10

No results posted yet for this study

Summary

Total abdominal hysterectomy is known to be associated with operative blood loss, which can lead to patients' morbidity. Misoprostol, a prostaglandin, has been shown to be effective in reducing operative blood loss during myomectomy. It is the first study to investigate if preoperative misoprostol is effective in reducing operative blood loss during total abdominal hysterectomy.

Conditions

  • Hysterectomy

Interventions

DRUG

Misoprostol

400mcg misoprostol given sublingually 30 minutes before total abdominal hysterectomy

DRUG

Vitamin B 6

20mg vitamin B6 given sublingually 30 minutes before total abdominal hysterectomy

Sponsors & Collaborators

  • The University of Hong Kong

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-01-31
Primary Completion
2008-04-30
Completion
2008-04-30

Countries

  • Hong Kong

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01199159 on ClinicalTrials.gov